File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Definitive radiotherapy for early stage glottic cancer by 6 MV photons

TitleDefinitive radiotherapy for early stage glottic cancer by 6 MV photons
Authors
Tong, Chi ChungAu, Kwok HungNgan, Roger Kai CheongCheung, Foon YiuChow, Sin MingFu, Yiu TungAu, Joseph Siu KeiLaw, Stephen Chun Key
KeywordsT1/T2N0 glottic cancer
Radiotherapy
Biologically effective dose
6MV photons
Issue Date2012
Citation
Head and Neck Oncology, 2012, v. 4, n. 1 How to Cite?
DOI: http://dx.doi.org/10.1186/1758-3284-4-23
AbstractPurpose: To evaluate the clinical outcome of early glottic cancer (GC) treated by primary radiotherapy (RT) with 6 MV photons. Methods and materials: We retrospectively reviewed the medical records of 695 consecutive patients with T1N0 and T2N0 GC treated between 1983 and 2005 by RT in our institution. Clinical outcome in terms of local control (LC), overall survival (OS) and cause- specific survival (CSS) rate were evaluated. Results: The median follow-up time was 10.5 years.The 10-year actuarial LC rates were as follows: T1A, 91%; T1B, 87%; T2, 77%. The 10-year OS were as follows: T1, 74.2%; T2, 70.7%. The 10-year CSS were as follows: T1, 97.7%; T2, 97.1%. Poorly differentiated histology and tumor biologically effective dose < 65 Gy.© 2012 Tong et al.; licensee BioMed Central Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/251614
ISI Accession Number ID
WOS:000308992600001

 

DC FieldValueLanguage
dc.contributor.authorTong, Chi Chung-
dc.contributor.authorAu, Kwok Hung-
dc.contributor.authorNgan, Roger Kai Cheong-
dc.contributor.authorCheung, Foon Yiu-
dc.contributor.authorChow, Sin Ming-
dc.contributor.authorFu, Yiu Tung-
dc.contributor.authorAu, Joseph Siu Kei-
dc.contributor.authorLaw, Stephen Chun Key-
dc.date.accessioned2018-03-08T05:00:29Z-
dc.date.available2018-03-08T05:00:29Z-
dc.date.issued2012-
dc.identifier.citationHead and Neck Oncology, 2012, v. 4, n. 1-
dc.identifier.urihttp://hdl.handle.net/10722/251614-
dc.description.abstractPurpose: To evaluate the clinical outcome of early glottic cancer (GC) treated by primary radiotherapy (RT) with 6 MV photons. Methods and materials: We retrospectively reviewed the medical records of 695 consecutive patients with T1N0 and T2N0 GC treated between 1983 and 2005 by RT in our institution. Clinical outcome in terms of local control (LC), overall survival (OS) and cause- specific survival (CSS) rate were evaluated. Results: The median follow-up time was 10.5 years.The 10-year actuarial LC rates were as follows: T1A, 91%; T1B, 87%; T2, 77%. The 10-year OS were as follows: T1, 74.2%; T2, 70.7%. The 10-year CSS were as follows: T1, 97.7%; T2, 97.1%. Poorly differentiated histology and tumor biologically effective dose < 65 Gy.© 2012 Tong et al.; licensee BioMed Central Ltd.-
dc.languageeng-
dc.relation.ispartofHead and Neck Oncology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectT1/T2N0 glottic cancer-
dc.subjectRadiotherapy-
dc.subjectBiologically effective dose-
dc.subject6MV photons-
dc.titleDefinitive radiotherapy for early stage glottic cancer by 6 MV photons-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/1758-3284-4-23-
dc.identifier.pmid22607730-
dc.identifier.scopuseid_2-s2.0-84861157371-
dc.identifier.volume4-
dc.identifier.issue1-
dc.identifier.spagenull-
dc.identifier.epagenull-
dc.identifier.eissn1758-3284-
dc.identifier.isiWOS:000308992600001-
dc.identifier.issnl1758-3284-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats